BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34882306)

  • 21. Different Roles of p62 (SQSTM1) Isoforms in Keratin-Related Protein Aggregation.
    Somlapura M; Gottschalk B; Lahiri P; Kufferath I; Pabst D; Rülicke T; Graier WF; Denk H; Zatloukal K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SQSTM1/p62 promotes miR-198 loading into extracellular vesicles and its autophagy-related secretion.
    Yu X; Eischeid-Scholz H; Meder L; Kondylis V; Büttner R; Odenthal M
    Hum Cell; 2022 Nov; 35(6):1766-1784. PubMed ID: 36050615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62.
    Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Hepatology; 2007 Sep; 46(3):851-60. PubMed ID: 17685470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Teas from Penthorum chinense Pursh Alleviates Ethanol-Induced Hepatic Oxidative Stress and Autophagy Impairment in Zebrafish via Modulating the AMPK/p62/Nrf2/mTOR Signaling Axis.
    Zhao X; Zhou M; Deng Y; Guo C; Liao L; He L; Peng C; Li Y
    Plant Foods Hum Nutr; 2022 Dec; 77(4):514-520. PubMed ID: 36103040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system.
    Sánchez-Martín P; Sou YS; Kageyama S; Koike M; Waguri S; Komatsu M
    EMBO Rep; 2020 Mar; 21(3):e48902. PubMed ID: 31916398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.
    Green CD; Weigel C; Brown RDR; Bedossa P; Dozmorov M; Sanyal AJ; Spiegel S
    FASEB J; 2022 Jul; 36(7):e22372. PubMed ID: 35639028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.
    Mildenberger J; Johansson I; Sergin I; Kjøbli E; Damås JK; Razani B; Flo TH; Bjørkøy G
    Autophagy; 2017 Oct; 13(10):1664-1678. PubMed ID: 28820283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipotoxicity reduces DDX58/Rig-1 expression and activity leading to impaired autophagy and cell death.
    Frietze KK; Brown AM; Das D; Franks RG; Cunningham JL; Hayward M; Nickels JT
    Autophagy; 2022 Jan; 18(1):142-160. PubMed ID: 33966599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.
    Duran A; Hernandez ED; Reina-Campos M; Castilla EA; Subramaniam S; Raghunandan S; Roberts LR; Kisseleva T; Karin M; Diaz-Meco MT; Moscat J
    Cancer Cell; 2016 Oct; 30(4):595-609. PubMed ID: 27728806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
    Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
    Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity.
    Park JS; Lee DH; Lee YS; Oh E; Bae KH; Oh KJ; Kim H; Bae SH
    Autophagy; 2020 Jan; 16(1):86-105. PubMed ID: 30907226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired autophagy response in human hepatocellular carcinoma.
    Bao L; Chandra PK; Moroz K; Zhang X; Thung SN; Wu T; Dash S
    Exp Mol Pathol; 2014 Apr; 96(2):149-54. PubMed ID: 24369267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
    Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
    J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1-mediated p62/sequestosome 1 phosphorylation.
    Cho CS; Park HW; Ho A; Semple IA; Kim B; Jang I; Park H; Reilly S; Saltiel AR; Lee JH
    Hepatology; 2018 Oct; 68(4):1331-1346. PubMed ID: 29251796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in molecular function of p62 protein and its role in diseases].
    Sui X; Xu P; Duan C; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1374-1389. PubMed ID: 37154312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1.
    Komatsu M; Kurokawa H; Waguri S; Taguchi K; Kobayashi A; Ichimura Y; Sou YS; Ueno I; Sakamoto A; Tong KI; Kim M; Nishito Y; Iemura S; Natsume T; Ueno T; Kominami E; Motohashi H; Tanaka K; Yamamoto M
    Nat Cell Biol; 2010 Mar; 12(3):213-23. PubMed ID: 20173742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).
    Jia Y; Ji P; French B; Tillman B; French SW
    Exp Mol Pathol; 2019 Jun; 108():156-163. PubMed ID: 30951700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
    Zhang XW; Zhou JC; Peng D; Hua F; Li K; Yu JJ; Lv XX; Cui B; Liu SS; Yu JM; Wang F; Jin CC; Yang ZN; Zhao CX; Hou XY; Huang B; Hu ZW
    Autophagy; 2020 May; 16(5):782-796. PubMed ID: 31286822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.
    Stumptner C; Heid H; Fuchsbichler A; Hauser H; Mischinger HJ; Zatloukal K; Denk H
    Am J Pathol; 1999 Jun; 154(6):1701-10. PubMed ID: 10362795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.